← Browse by Condition
Medical Condition

egf r positive non small cell lung cancer

Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1, Phase 2
NCT06109558 Phase 1, Phase 2
Recruiting

The Efficacy and Safety of LMV-12 Combined With Osimertinib in NSCLC

Enrollment
120 pts
Location
China
Sponsor
Hunan Province Tumor Hospital
View Trial →
NCT06352502
Recruiting

An Observational Study of Furmonertinib for EGFR Mutation-positive NSCLC Patients With Brain Metastasis

Enrollment
30 pts
Location
China
Sponsor
Tang-Du Hospital
View Trial →